DS
Devinjit Singh
About Devinjit Singh
Data last updated:
Devinjit Singh is a Director at Medsource Ozone Biomedicals Private Limited (since 2021), Director at Respo Financial Capital Private Limited (since 2021) and Designated Partner at Xponentia Capital Partners Llp (since 2018), and holds 6 more current directorships. The companies operate in Healthcare, Financial Services and Business Outsourcing. The 3 current companies with reported revenue have a combined latest revenue of ₹291 Cr; the largest is Medsource Ozone Biomedicals Private Limited at ₹173 Cr (FY 2024). Earlier, Devinjit Singh was a Director at United Foodbrands Limited (2020–2025) and Partner at Alpha Alternatives Msar Llp (2022–2023) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medsource Ozone Biomedicals Private Limited U85100DL2003PTC120213 | Director | 02 Dec 2021 | 2003 | ₹173 Cr (FY 2024) | Active |
 Respo Financial Capital Private Limited U65990MH2021PTC373655 | Director | 21 Dec 2021 | 2021 | ₹104 Cr (FY 2025) | Active |
 Xponentia Capital Partners Llp AAA-2937 | Designated Partner | 10 Jun 2018 | 2010 | ₹14.36 Cr (FY 2023) | Active |
 Xponentia Fund Partners Iii Llp ACI-9796 | Designated Partner | 14 Aug 2024 | 2024 | Active | |
| Xponentia Benefits Llp ACG-1329 | Designated Partner | 18 Mar 2024 | 2024 | Active | |
| Xponentia Fund Partners Ii Llp AAY-8101 | Designated Partner | 29 Sep 2021 | 2021 | Active | |
| Capri Xponentia Managers Llp AAU-3565 | Partner | 18 Dec 2020 | 2020 | Active | |
| Capri Associates Llp AAU-3774 | Partner | 18 Dec 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 United Foodbrands Limited L55101KA2006PLC073031 | Director | 31 Dec 2020 | 2006 | ₹1,249 Cr (FY 2025) | Active |
| Alpha Alternatives Msar Llp AAW-2814 | Partner | 02 Aug 2022 | 2021 | ₹4,486 Cr (FY 2025) | Active |
 Carlyle India Advisors Private Limited U74140MH2000PTC167855 | Managing Director | 30 Jun 2008 | 2000 | ₹190 Cr (FY 2025) | Active |
 Sbi Capital Markets Limited U99999MH1986PLC040298 | Director | 24 Feb 2015 | 1986 | ₹3,432 Cr (FY 2025) | Active |
 Sbi Cards And Payment Services Limited L65999DL1998PLC093849 | Nominee Director | 15 Dec 2017 | 1998 | ₹5,144 Cr (FY 2018) | Active |
 Pnb Housing Finance Limited L65922DL1988PLC033856 | Director | 05 Mar 2015 | 1988 | ₹8,505 Cr (FY 2026) | Active |
| Destimoney Enterprises Limited U70100MH2005PLC155887 | Director | 12 Feb 2015 | 2005 | ₹14.00 Cr (FY 2016) | Dissolved (Liquidated) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Devinjit Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prateek Kumar Mittal | 00639787 | Medsource Ozone Biomedicals Private Limited | Director |
| Shailesh Kumar Mittal | 00432708 | Medsource Ozone Biomedicals Private Limited | Director |
| Ashish Shantilal Ranka | Respo Financial Capital Private Limited | Cfo | |
| Perumal Ramamurthy Srinivasan | 00365025 | Respo Financial Capital Private Limited , Xponentia Capital Partners Llp and 6 more | Director |
| Rahul Bahri | 08486345 | Respo Financial Capital Private Limited | Director |
| Vivek Vig | 01117418 | Respo Financial Capital Private Limited | Director |
| Yogi Sadana | Respo Financial Capital Private Limited | Ceo | |
| Rajesh Sharma | 00020037 | Capri Xponentia Managers Llp , Capri Associates Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devinjit Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devinjit Singh
Devinjit Singh currently holds 9 directorships: Medsource Ozone Biomedicals Private Limited (Director, since 02 Dec 2021, revenue ₹173 Cr (FY 2024)); Respo Financial Capital Private Limited (Director, since 21 Dec 2021, revenue ₹104 Cr (FY 2025)); Xponentia Capital Partners Llp (Designated Partner, since 10 Jun 2018, revenue ₹14.36 Cr (FY 2023)); Xponentia Fund Partners Iii Llp (Designated Partner, since 14 Aug 2024); Xponentia Benefits Llp (Designated Partner, since 18 Mar 2024); and 4 more.
Devinjit Singh was first appointed on 30 Jun 2008 as Managing Director at Carlyle India Advisors Private Limited. The most recent appointment on record is 14 Aug 2024 at Xponentia Fund Partners Iii Llp.
The 3 current companies of Devinjit Singh that report revenue have a combined latest revenue of ₹291 Cr: Medsource Ozone Biomedicals Private Limited ₹173 Cr (FY 2024); Respo Financial Capital Private Limited ₹104 Cr (FY 2025); Xponentia Capital Partners Llp ₹14.36 Cr (FY 2023).
Devinjit Singh held 7 earlier board appointments: United Foodbrands Limited (Director, 31 Dec 2020 to 03 Feb 2025); Alpha Alternatives Msar Llp (Partner, 02 Aug 2022 to 01 Nov 2023); Carlyle India Advisors Private Limited (Managing Director, 30 Jun 2008 to 01 Jul 2018); Sbi Capital Markets Limited (Director, 24 Feb 2015 to 19 Aug 2017); Sbi Cards And Payment Services Limited (Nominee Director, 15 Dec 2017 to 04 Sep 2018); and 2 more.
The current boards of Devinjit Singh's companies include Prateek Kumar Mittal (Medsource Ozone Biomedicals Private Limited), Shailesh Kumar Mittal (Medsource Ozone Biomedicals Private Limited), Ashish Shantilal Ranka (Respo Financial Capital Private Limited), Perumal Ramamurthy Srinivasan (Respo Financial Capital Private Limited), Rahul Bahri (Respo Financial Capital Private Limited), Vivek Vig (Respo Financial Capital Private Limited), among others.